BioCentury
ARTICLE | Clinical News

Geron preclinical data

January 11, 2010 8:00 AM UTC

In mouse xenograft models of glioblastoma, imetelstat significantly reduced tumor growth rate and led to a 10-fold decrease in tumor size after 53 days of treatment vs. vehicle. Imetelstat also inhibi...